Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209098) titled 'Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure' on Sept. 30.

Study Type: Observational

Primary Sponsor: Impulse Dynamics

Condition: Heart Failure and Reduced Ejection Fraction NYHA Class III Heart Failure

Intervention: Device: Cardiac Contractility Modulation (CCM)

Recruitment Status: Not recruiting

Date of First Enrollment: October 2025

Target Sample Size: 4200

To know more, visit https://clinicaltrials.gov/study/NCT07209098

Published by HT Digital Content Services with permission from Health Daily Digest....